Active Ingredient: MITOMYCIN
Proprietary Name: MITOZYTREX
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 5MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N050763
Product Number: 001
Approval Date: Nov 14, 2002
Applicant Holder Full Name: SUPERGEN INC
Marketing Status:
Discontinued
Patent and Exclusivity Information
